2026年11月4日星期三
M
Meridian Globe
ព័ត៌មានបន្ទាន់
Mitsui Chemicals to buy Japan chip material maker JSR for over $8.2bn— 日经 Nikkei AsiaPetrovietnam CEO sees a future of nuclear and wind power— 日经 Nikkei AsiaTaiwan airlines continue flights over Russia, rattling Europeans— 日经 Nikkei AsiaDebt costs curb growth for developing nations, Rockefeller official says— 日经 Nikkei AsiaChina's Temu, JD.com revamp business models amid tariff headwinds— 日经 Nikkei AsiaNidec's rise and fall fuels calls for sweeping overhaul of Japanese company— 日经 Nikkei AsiaAPEC host China to keep cars off street, close schools during Shenzhen summit— 日经 Nikkei AsiaJapan regional banks form united front on cybersecurity— 日经 Nikkei AsiaMitsui Chemicals to buy Japan chip material maker JSR for over $8.2bn— 日经 Nikkei AsiaPetrovietnam CEO sees a future of nuclear and wind power— 日经 Nikkei AsiaTaiwan airlines continue flights over Russia, rattling Europeans— 日经 Nikkei AsiaDebt costs curb growth for developing nations, Rockefeller official says— 日经 Nikkei AsiaChina's Temu, JD.com revamp business models amid tariff headwinds— 日经 Nikkei AsiaNidec's rise and fall fuels calls for sweeping overhaul of Japanese company— 日经 Nikkei AsiaAPEC host China to keep cars off street, close schools during Shenzhen summit— 日经 Nikkei AsiaJapan regional banks form united front on cybersecurity— 日经 Nikkei Asia

Anti-PD1 immunotherapy in MHC-I dysregulated head and neck cancer promotes metastasis via CD8+ T-cell insufficiency

ប្រភព Nature 生命科学6 ថ្ងៃមុន
Summary

យើងផ្តល់តែសន្ទស្សន៍ចំណងជើង និងសេចក្តីសង្ខេប។ ខ្លឹមសារពេញលេញ និងសិទ្ធិអ្នកនិពន្ធ ជាកម្មសិទ្ធិរបស់ប្រភពដើម — សូមចុចតំណដើមដើម្បីអាន។

បើកឯកសារដើម
ផ្នែកព័ត៌មាន
Science
តំបន់
Global
Language
English
Item ID
science-7a494cc6

Comments 0 comments

No comments yet. Be the first.

Anti-PD1 immunotherapy in MHC-I dysregulated head and neck cancer promotes metastasis via CD8+ T-cell insufficiency · Meridian Globe